肉毒毒素A治疗糖尿病神经病变相关肌肉痉挛的疗效
这项单中心、双盲、安慰剂对照的前瞻性研究纳入50例伴周围神经病变和难治性小腿或足部痉挛的糖尿病患者,随机分两组,分别肌肉注射肉毒毒素A(100或30单位)或生理盐水。结果显示肉毒毒素A组所有结局指标较安慰剂组显著改善,仅5/25(20%)为无应答者,注射部位轻度疼痛为唯一不良事件。
要点
- 肉毒毒素A肌肉注射可显著改善糖尿病神经病变相关肌肉痉挛的疼痛强度和痉挛频率。
- 疗效在注射后1周即显著,持续至第14周;19例应答者5个月后重复注射,效果与首次相似。
- 仅5/25(20%)患者为无应答者(主要结局改善<50%),注射部位轻度疼痛(4/25例)为唯一不良事件,2至3天内消失。
核心结论
- 局部注射肉毒毒素A是使糖尿病神经病变相关肌肉痉挛获得持续改善的有效且安全的方法。
研究设计与样本
- 单中心、双盲、安慰剂对照的前瞻性研究,纳入50例伴周围神经病变且小腿或足部痉挛对常用药物难治的糖尿病患者,随机分入2个匹配组。
- 肉毒毒素A(100或30单位)或生理盐水注射于每侧腓肠肌或足部小屈肌。
- 主要结局为疼痛强度变化,同时评估痉挛频率、痉挛对日常生活的干扰及电生理痉挛阈值频率,随访20周;19例应答者在首次注射5个月后重复治疗。
主要发现
- 肉毒毒素A组所有结局指标较安慰剂组显著改善。
- 较基线的变化在1周后即显著,并持续至第14周。
- 仅5/25(20%)患者为无应答者(主要结局下降<50%)。
- 第二次肉毒毒素A注射的应答与首次给药相似。
- 注射部位轻度疼痛(4/25例)是唯一不良事件,2至3天内消失。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Muscle cramps occur in >50% of diabetic patients and reduce the quality of life. No effective treatment is available. We evaluated the clinical effectiveness of botulinum toxin A (BTX-A) injections for treating cramps in diabetic patients with neuropathy. METHODS: This single-center, double-blind, placebo-controlled perspective study investigated the efficacy and safety of BTX-A intramuscular injection for treating calf or foot cramps refractory to common pharmacological drugs. Fifty diabetic patients with peripheral neuropathy and cramps were randomly assigned to 2 matched groups. BTX-A (100 or 30 units) or saline was injected on each side into the gastrocnemius or the small flexor foot muscles. Changes in pain intensity (primary outcome) and cramp frequency were evaluated over the course of 20 weeks after BTX-A administration. Cramp interference in daily life and the electrophysiological cramp threshold frequency were also measured. The treatment was repeated 5 months after first injection in 19 responders. RESULTS: All outcome measures improved significantly after BTX-A compared with placebo. The changes with respect to baseline were already significant after 1 week and persisted up to week 14. Only 5 of 25 (20%) patients were nonresponders (<50% decrease of the primary outcome). The responses to a second BTX-A injection provided results similar to the first administration. Mild pain at the injection site (4/25 cases) was the only adverse event, and it disappeared within 2 to 3 days. INTERPRETATION: Local BTX-A infiltration is an efficacious and safe procedure for obtaining a sustained amelioration of muscle cramps associated with diabetic neuropathy. Ann Neurol 2018;84:682-690.
引用
- Restivo DA, Casabona A, Frittitta L, et al. Efficacy of Botulinum Toxin A for Treating Cramps in Diabetic Neuropathy. Ann Neurol. 2018. PMID: 30225985. doi:10.1002/ana.25340
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。